The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
about
Multifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatmentStructure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptorsA translocated bacterial protein protects vascular endothelial cells from apoptosis.Protein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis.Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2.The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.Proglucagon-derived peptides: mechanisms of action and therapeutic potential.Gut adaptation and the glucagon-like peptidesCyclic AMP is both a pro-apoptotic and anti-apoptotic second messengerMechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblastsIrinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Class II G protein-coupled receptors and their ligands in neuronal function and protectionTeduglutide for the treatment of short bowel syndrome.Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.Development of the infant intestine: implications for nutrition support.Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.The inhibitory effect of dibutyryl cyclic AMP on docosahexaenoic acid-induced apoptosis in HL-60 cells through activation of the phosphatidylinositol-3 kinase pathwayThe therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease.Cyclic AMP activation of the extracellular signal-regulated kinases 1 and 2: implications for intestinal cell survival through the transient inhibition of apoptosis.Activation of adenylyl cyclases, regulation of insulin status, and cell survival by G(alpha)olf in pancreatic beta-cells.The endogenous preproglucagon system is not essential for gut growth homeostasis in miceGlucagon-like peptide 2 induces vasoactive intestinal polypeptide expression in enteric neurons via phophatidylinositol 3-kinase-γ signaling.Intestinal hormones and growth factors: effects on the small intestine.cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release.Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c.Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis.GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets.
P2860
Q28086792-42840559-1CEB-4308-9463-E2D7626B41CFQ28203273-9A205855-D083-4934-95FD-E5532C2FACE2Q33264405-24A8E5F8-E4E7-488A-9B4F-D815185256A4Q33443097-F65EB253-AB63-4AA5-844C-4E2460A5ABBEQ34281175-B5653F85-336B-4D8A-B0EC-674209559334Q34409674-7E706213-7E72-4F79-92D8-085A584B9CBBQ34452524-06C20F93-41EF-4CA6-B9CD-D62D83C60271Q34526042-32131FE3-A120-40CE-9F71-C58A7868DBE4Q35074567-CEF9CC4B-9625-44FD-91B6-B5D409565C0DQ36063090-5F194FE6-A8BA-4D8C-A548-D10F04122759Q36171894-6F52F553-CCFF-41F7-9896-0BA7D42ADFFEQ36211439-0FA39A8F-12B7-45AA-B981-5D7EEAC06AFAQ36480664-922C1DF7-7EEA-4848-8BC8-A59A2F9154E4Q36710038-22DF418C-13A2-4BA3-8970-DEED18DCA2E7Q36765302-78CAA660-6710-4AAC-AA57-0BB4EE6BCD36Q37031716-3F53FF1C-D26A-4513-896C-A4F6BF6FF2FEQ37295891-A4CBE94B-B2E0-459E-9D65-1AA2378B4A6CQ37840099-70EFECCE-EBF4-4B99-B7E4-D5E16B123292Q40595331-5FA1B94F-DA5B-400B-8F02-FB968326112CQ40752353-FA0092F0-BBC3-4FBC-9E75-83D05BBE2578Q41038731-20A2A7D4-1657-4F93-9144-A6B7CAE7FD31Q42428793-383D03E8-3737-47EA-805D-BDB4E5527040Q43166019-97B0DD98-1BD4-4E6D-9AE4-8CE8205F5E4EQ44104039-FFFAB96A-CAFC-40C1-90C9-FE2FEA2C8EA2Q44764155-07326F54-2374-403B-B0A3-32F1103A6F9BQ45259224-0A5BAE92-D553-42C2-A2CC-AB8D5100F4EAQ47882828-D99929CE-9ECC-4890-AA32-37D13DB6236AQ54211552-24A7E9DA-EE35-422A-B20C-CB05D3CD235C
P2860
The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The glucagon-like peptide-2 re ...... in kinase-independent pathway.
@en
type
label
The glucagon-like peptide-2 re ...... in kinase-independent pathway.
@en
prefLabel
The glucagon-like peptide-2 re ...... in kinase-independent pathway.
@en
P2093
P2860
P356
P1476
The glucagon-like peptide-2 re ...... in kinase-independent pathway.
@en
P2093
P2860
P304
35345-35352
P356
10.1074/JBC.M005510200
P407
P577
2000-11-01T00:00:00Z